Le Lézard
Classified in: Health
Subjects: LAW, EXE, HSP, WOM, AVO

March of Dimes Hails King v. Burwell Decision

WASHINGTON, June 25, 2015 /PRNewswire-USNewswire/ -- The March of Dimes, the nation's leading advocacy organization for maternal and child health, today hailed the Supreme Court's decision upholding the Constitutionality of tax subsidies provided to those who purchase health insurance through Health Insurance Marketplaces, regardless of whether those Marketplaces are established and maintained by states or the federal government.

March of Dimes Foundation Logo

"This decision is a victory for women and families," stated March of Dimes President Dr. Jennifer L. Howse.  "The tax credits provided under the Affordable Care Act are enabling millions of women and families to purchase affordable health insurance in Health Insurance Marketplaces.  We're gratified that the Supreme Court accepted the arguments put forth by the March of Dimes and our allies supporting the legality of the ACA tax subsidies."

In King v. Burwell, a group of individuals challenged the availability of tax credits to purchase health insurance under the Patient Protection and Affordable Care Act of 2010 (ACA), arguing that one phrase in the voluminous law limited the availability of tax credits only to coverage purchased through Health Insurance Marketplaces established by states.  If this case had succeeded, tax subsidies to make coverage affordable would have been denied to the millions of Americans who have purchased plans through Health Insurance Marketplaces operated by the federal government.

"Women need to have coverage throughout their lives, both to maintain their own good health and to ensure healthy pregnancies," Dr. Howse added.  "If women can only obtain coverage while pregnant, or not even then, the evidence is overwhelming that both they and their infants suffer poor health outcomes.  We need to do more to ensure women and families have access to affordable, quality coverage, not take it away from them."

In January, the March of Dimes joined other organizations in filing an amicus curiae brief with the Supreme Court urging rejection of the petitioners' arguments, making three key legal arguments:

The amicus brief was also signed by the American Academy of Pediatrics, the American Academy of Family Physicians, the Children's Health Fund, Children's Hospitals Association, First Focus, and National Physicians Alliance, as well as several individuals with health conditions who have been able to obtain affordable coverage with tax credits provided under the Affordable Care Act.

About March of Dimes
The March of Dimes is a national voluntary health agency whose volunteers and staff work to improve the health of infants and children by preventing birth defects, premature birth and infant mortality. Founded in 1938, the March of Dimes funds programs of research, community services, education and advocacy. For the latest resources and information, visit marchofdimes.org or nacersano.org.  Find us on Facebook and follow us on Twitter.

Logo - http://photos.prnewswire.com/prnh/20150409/197662LOGO


SOURCE March of Dimes

These press releases may also interest you

at 06:55
Waters Corporation today announced first quarter 2019 sales of $514 million, a 3% decrease as reported, compared to sales of $531 million for the first quarter of 2018. Foreign currency translation negatively impacted sales...

at 06:50
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present at the upcoming Bloom Burton & Co. Healthcare Investor Conference taking place...

at 06:50
Global sinus dilation devices market is expected to grow at a significant CAGR of 6.04% by 2023 as the scope and its applications are rising enormously across the globe. Sinus dilation device is catheter-based, FDA-cleared technologies precisely...

at 06:45
Quest Diagnostics Incorporated , the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2019. "We're off to a good start in 2019, with...

at 06:45
Mallinckrodt plc , a leading global specialty pharmaceutical company, today confirmed it has completed enrollment in the company's Phase 4 clinical study assessing the efficacy and safety of Acthar® Gel in Systemic Lupus Erythematosus (lupus, SLE)...

at 06:30
ViewRay, Inc.  announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO), with a number of presentations and posters...

News published on 25 june 2015 at 11:07 and distributed by: